Our Chief Medical Officer, Dr. Robert Nussbaum, shares why this alternative model of service delivery is critical to bringing genetics into mainstream medicine. "From its inception, Invitae has been focused on reducing obstacles to genetic information," he says. "Patient-initiated testing is the next step in doing what Invitae has been doing all along. We want to make it easier for [patients] to get the testing they need."
Patients too often face challenges when seeking genetic testing for health reasons, such as lack of local providers, long wait times, and restrictive testing guidelines or payer policies. In addition, more and more patients are receiving information from direct-to-consumer tests that are ill-suited to answer their health questions. These tests provide incomplete analysis, often do not involve clinicians, and fail to include important genes and thus have high clinical false-negative rates.
Clinicians who are not experts in genetics also tell us they wish they had a trusted resource that provided a high-quality, medically-responsible, and self-guided ordering experience for their patients with appropriate support from genetics experts.
Our new service has been designed with all these needs in mind.
We view this as an alternative model of service delivery that utilizes telemedicine to provide high-quality genetic counseling and testing to patients who are interested in driving this process themselves, either because of geographic distance, logistical barriers, or personal preference. We anticipate that this channel will be commonly used by the following populations:
We have included clinical review and support, access to genetic counseling, and the ability to share results with providers, creating a telemedicine-enabled testing service that provides medically responsible, high-quality care for patients.
For more than five years, we have worked hard to earn your trust. With the growing body of evidence supporting the use of genetics in mainstream medicine, we are committed to expanding access to genetics in a medically-responsible way, to connecting patients and providers to improve medical outcomes, and to do so while lowering the cost of healthcare. This new model of delivering genetic information reflects that commitment.